Jove
Visualize
Contact Us

Related Experiment Videos

Caring for the renal failure patient: optimizing iron therapy.

Vaughn W Folkert1, Asuncion M Javier, Neeta B O'Mara

  • 1Weiler Hospital, Albert Einstein College of Medicine, Montefiore Medical Center, Bronx, NY, USA.

Nephrology Nursing Journal : Journal of the American Nephrology Nurses' Association
|February 25, 2003
PubMed
Summary

Iron deficiency significantly impacts anemia management in end-stage renal disease (ESRD) patients, reducing treatment effectiveness. Addressing iron deficiency rigorously with early evaluation and aggressive therapy can improve hemoglobin levels and patient outcomes.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Modeled Daily Ingested, Absorbed and Bound Phosphorus: New Measures of Mineral Balance in Hemodialysis Patients.

American journal of nephrology·2019
Same author

Vascular access placement in patients with chronic kidney disease Stages 4 and 5 attending an inner city nephrology clinic: a cohort study and survey of providers.

BMC nephrology·2017
Same author

Hidden Obesity in Dialysis Patients: Clinical Implications.

Seminars in dialysis·2016
Same author

Variability in monthly serum bicarbonate measures in hemodialysis patients: a cohort study.

BMC nephrology·2015
Same author

Renal function recovery in chronic dialysis patients.

Seminars in dialysis·2010
Same author

Anemia therapy in ESRD: time to move on.

Clinical journal of the American Society of Nephrology : CJASN·2010
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Area of Science:

  • Nephrology
  • Hematology
  • Internal Medicine

Background:

  • Anemia management in end-stage renal disease (ESRD) has improved, yet many patients do not meet recommended hemoglobin (Hgb) levels.
  • Iron deficiency is a prevalent issue in predialysis and dialysis patients, hindering anemia treatment.
  • Iron is crucial for Hgb synthesis; its depletion exacerbates anemia and diminishes response to recombinant erythropoietin (rEPO) therapy.

Purpose of the Study:

  • To highlight the critical role of iron deficiency in suboptimal anemia management for ESRD patients.
  • To advocate for more rigorous iron deficiency assessment and treatment protocols.
  • To improve patient outcomes by optimizing iron therapy and preventing iron depletion.

Main Methods:

  • Review of current anemia management practices in ESRD.

Related Experiment Videos

  • Analysis of the impact of iron deficiency on hemoglobin levels and rEPO therapy response.
  • Discussion of strategies for early iron status evaluation and aggressive iron supplementation.
  • Emphasis on implementing maintenance iron regimens to prevent recurrence.

    • Main Results:

    • Approximately 26% of treated ESRD patients fail to achieve the target Hgb of 11 g/dl.
    • Iron deficiency is a major obstacle, reducing the efficacy of anemia treatments, including rEPO.
    • Proactive iron management protocols can significantly enhance treatment effectiveness.

    Conclusions:

    • Rigorous management of iron deficiency is essential for improving anemia control in ESRD patients.
    • Early iron status evaluation and aggressive iron therapy are key components of an effective protocol.
    • Optimized iron supplementation and maintenance regimens can prevent recurrence and improve patient outcomes.